| CAT No: | CL-CTX-02 |
| CAS No: | 92143-31-2 |
| Mol.F: | C18H18N8O7S3 |
| Mol.Wt.: | 554.6 |
| Chemical Name: | (6R,7R)-7-[[(2E)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ; (6R,7R)-7-[(E)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido]-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per USP) |
| Inventory Status: | Custom synthesis |
This impurity is related to Ceftriaxone EP Impurity A is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Ceftriaxone EP Impurity A is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(6R,7R)-7-[[(2E)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ; (6R,7R)-7-[(E)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido]-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per USP)Country of Origin: India Product Category: Impurity Reference StandardAPI NAME: Ceftriaxone Molecular Formula: C18H18N8O7S3
Molecular Weight: 554.6
Storage: Store in a cool, dry place.
| Product Name: | Ceftriaxone EP Impurity A |
| CAS No: | 92143-31-2 |
| Mol.F.: | C18H18N8O7S3 |
| Mol.Wt.: | 554.6 |
Cat. No: CL-CTX-NO-02
CAS No: NA
Mol. F: C17H17N9O8S3
Mol. Wt: 571.56
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-NO-03
CAS No: NA
Mol. F: C4H6N4O3S
Mol. Wt: 190.18
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-NO-04
CAS No: NA
Mol. F: C5H8N4O3S
Mol. Wt: 204.2
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-01
CAS No: NA
Mol. F: C18H18N8O7S3 : 2(Na) : (H2O)
Mol. Wt: 554.6 : 2(23.0) : (18.0)
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-03
CAS No: 66340-33-8
Mol. F: C14H13N5O5S2
Mol. Wt: 395.4
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-04
CAS No: 58909-39-0
Mol. F: C4H5N3O2S
Mol. Wt: 159.2
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-05
CAS No: 58909-56-1
Mol. F: C12H13N5O5S2
Mol. Wt: 371.4
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-06
CAS No: 80756-85-0
Mol. F: C13H10N4O2S3
Mol. Wt: 350.4
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-07
CAS No: 1684396-27-7
Mol. F: C13H10N4O2S3
Mol. Wt: 350.4
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-08
CAS No: 84994-24-1
Mol. F: C13H10N4O3S2
Mol. Wt: 334.4
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-09
CAS No: 959246-33-4
Mol. F: C13H10N4O2S3
Mol. Wt: 350.4
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-10
CAS No: 149-30-4
Mol. F: C7H5NS2
Mol. Wt: 167.2
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-11
CAS No: 219827-56-2
Mol. F: C16H17N5O7S2 : C6H15N
Mol. Wt: 455.5 : 101.2
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-12
CAS No: 64485-88-7
Mol. F: C8H11N3O3S
Mol. Wt: 229.3
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-13
CAS No: NA
Mol. F: C18H18N8O7S3
Mol. Wt: 554.6
Inv. Status: Custom Synthesis
Cat. No: CL-CTX-14
CAS No: 149-57-5
Mol. F: C8H16O2
Mol. Wt: 144.2
Inv. Status: Custom Synthesis
.jpg)
Cat. No: CL-CTX-15
CAS No: 957-68-6
Mol. F: C10H12N2O5S
Mol. Wt: 272.3
Inv. Status: Custom Synthesis
.jpg)
Cat. No: CL-CTX-16
CAS No: NA
Mol. F: C18H18N8O7S3
Mol. Wt: 554.6
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: